Magnetic Ventures

Megan Bent, the founder and managing partner, leads all investment decisions. Bent previously spent seven years as a managing director at Revel Partners and worked in life science banking at Silicon Valley Bank. That combination of venture investing and science banking shaped her thesis around biology-meets-software startups.

Magnetic focuses on seed and Series A rounds, entering early enough to shape company formation but with enough capital to lead or co-lead rounds. The firm deploys initial checks sized for the life science and enterprise software markets it serves, where both lab validation and go-to-market execution can be capital-intensive early.

Magnetic does not invest in therapeutic development, medical devices requiring FDA Class III approval, or pure-play consumer apps. The firm's thesis excludes anything that cannot connect a scientific or data-science advantage to a software-driven distribution model. Consumer hardware with no recurring data network effect also falls outside the mandate.

Megan Bent's network spans two distinct ecosystems — the traditional Silicon Valley venture stack and the academic science community, including university tech transfer offices and research hospitals. Magnetic also sources through its portfolio founders, who often surface emerging talent in computational biology, health data, and enterprise AI. The firm's Miami base extends that network into the growing Southeastern tech corridor.

Public records do not currently indicate a second fundraise. The firm raised its debut fund in 2021, and with a typical early-stage deployment cadence of three to four years for a fund of that vintage, a subsequent vehicle would likely be in formation or close to announcement.